Alere's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Alere Inc. (ALR)

Q2 2012 Earnings Call

August 8, 2012 8:30 AM ET


Doug Guarino – Director, Corporate Relation

Ron Zwanziger – Chairman and CEO

Dave Teitel – CFO


Dan Leonard – Leerink Swann

Jon Groberg – Macquarie Capital

John Putnam – Capstone Investments

Zarak Khurshid – Wedbush Securities

Isaac Ro – Goldman Sachs

Nicholas Jansen – Raymond James & Associates

Greg Simpson – Wunderlich Securities

Peter Lawson – Mizuho Securities



Good morning and welcome to the Alere Inc. Conference Call to discuss Second Quarter 2012 Results Conference Call. All participants will be in a listen-only mode. (Operator Instructions) Please note this event is being recorded.

And I would now like to turn the conference over to Doug Guarino, Director of Corporate Relations. Please go ahead.

Doug Guarino

Thank you, Emily, and good morning and welcome to the Alere conference call to discuss our results for the quarter ended June 30, 2012. We are joined today by Ron Zwanziger, Chairman and CEO, and Dave Teitel, CFO.

Before we get to that discussion though, I would first like to draw your attention to the fact that certain matters discussed in this conference call will constitute forward-looking statements within the meaning of the U.S. Securities Laws. These statements reflect our current views with respect to future events or financial performance and are based on management’s current assumptions and information currently available.

Actual results and the timing of certain events could differ materially from those projected or contemplated by the forward-looking statements due to numerous factors, including without limitation, our ability to successfully acquire and integrate our acquisitions and to recognize the expected benefits of restructuring and new business activities; our exposure to changes in interest rates and foreign currency exchange rates; our ability to successfully develop and commercialize products and services; the market acceptance of our products and services; continued acceptance of health management services by payers, providers and patients.

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Abbott CEO: Another Alere-Related Divestiture Coming Soon

Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

Quidel Diversifies With Alere's Triage Assets

Alere Shareholders Vote to Approve Amended Merger with Abbott